Norfloxacin is more effective than Rifaximin in avoiding bacterial translocation in an animal model of cirrhosis

Breath Testing for Small Intestinal Bacterial Overgrowth: A Means to Enrich Rifaximin Responders in IBS Patients?

(2016) Amit Gupta et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Randomized-controlled trial of rifaximin versus norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis

(2016) Asem Elfert et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Development of an experimental rat model of hyperammonemic encephalopathy and evaluation of the effects of rifaximin

(2016) Satoru Tamaoki et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Comparison of the in vitro susceptibility of rifaximin versus norfloxacin against multidrug resistant bacteria in a hospital setting. A proof-of-concept study for use in advanced cirrhosis: Table 1

(2015) J M Ramos et al.   GUT

The efficacy and the immunomodulatory effect of rifaximin in prophylaxis of spontaneous bacterial peritonitis in cirrhotic Egyptian patients

(2015) Tarek Mostafa et al.   Turkish Journal of Gastroenterology

Processing faecal samples: a step forward for standards in microbial community analysis

(2014) Alba Santiago et al.   BMC MICROBIOLOGY

Role of interleukin 10 in norfloxacin prevention of luminal free endotoxin translocation in mice with cirrhosis

(2014) Isabel Gómez-Hurtado et al.   JOURNAL OF HEPATOLOGY

Alterations of the human gut microbiome in liver cirrhosis

(2014) Nan Qin et al.   NATURE

Impact of Rifaximin on the Frequency and Characteristics of Spontaneous Bacterial Peritonitis in Patients with Liver Cirrhosis and Ascites

(2014) Philipp Lutz et al.   PLoS One

Guidelines for Diagnosis, Treatment and Prevention of Clostridium difficile Infections

(2013) Christina M Surawicz et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Effects of Rifaximin on Bacterial Translocation in Thioacetamide-Induced Liver Injury in Rats

(2012) Murat M. M. Harputluoglu et al.   INFLAMMATION

The Role of Rifaximin in the Primary Prophylaxis of Spontaneous Bacterial Peritonitis in Patients With Liver Cirrhosis

(2012) Mohamad A. Hanouneh et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Characterization of fecal microbial communities in patients with liver cirrhosis

(2011) Yanfei Chen et al.   HEPATOLOGY

Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study

(2011) Javier Fernández et al.   HEPATOLOGY

Gut Microbiota Dysbiosis Is Associated with Inflammation and Bacterial Translocation in Mice with CCl4-Induced Fibrosis

(2011) Isabel Gómez-Hurtado et al.   PLoS One

Drug therapy: Rifaximin1

(2010) Jasmohan S. Bajaj et al.   HEPATOLOGY

Enteric dysbiosis associated with a mouse model of alcoholic liver disease

(2010) Arthur W. Yan et al.   HEPATOLOGY

Interleukin-10-mediated heme oxygenase 1-induced underlying mechanism in inflammatory down-regulation by norfloxacin in cirrhosis

(2010) Isabel Gómez-Hurtado et al.   HEPATOLOGY

Rifaximin-induced alteration of virulence of diarrhoea-producing Escherichia coli and Shigella sonnei

(2010) Zhi-Dong Jiang et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Rifaximin Treatment in Hepatic Encephalopathy

(2010) Nathan M. Bass et al.   NEW ENGLAND JOURNAL OF MEDICINE